13F HOLDINGS REPORT
Soleus Capital Management, L.P.
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001802630-24-000012
Total Value
$1.29B
Positions
87
Other Managers
0
Confidential Omitted
No
Holdings (87)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 900,000 | $88.9M | 6.89% |
| 2 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 8,528,500 | $80.1M | 6.20% |
| 3 | TG THERAPEUTICS INC | TGTX | 2,534,540 | $59.3M | 4.59% |
| 4 | TERNS PHARMACEUTICALS INC | TERN | 6,223,544 | $51.9M | 4.02% |
| 5 | AXOGEN INC | AXGN | 3,005,943 | $42.1M | 3.26% |
| 6 | GRIFOLS S A | GIKLY | 4,521,703 | $40.2M | 3.11% |
| 7 | KRYSTAL BIOTECH INC | KRYS | 216,979 | $39.5M | 3.06% |
| 8 | C4 THERAPEUTICS INC | CCCC | 6,603,996 | $37.6M | 2.91% |
| 9 | UNITED THERAPEUTICS CORP DEL | UTHR | 101,894 | $36.5M | 2.83% |
| 10 | SANOFI | SNYNF | 612,000 | $35.3M | 2.73% |
| 11 | ORGANOGENESIS HLDGS INC | ORGO | 11,839,876 | $33.9M | 2.62% |
| 12 | IDEAYA BIOSCIENCES INC | IDYA | 1,049,314 | $33.2M | 2.57% |
| 13 | REVOLUTION MEDICINES INC | RVMDW | 704,584 | $32.0M | 2.47% |
| 14 | QUIDELORTHO CORP | QDEL | 686,000 | $31.3M | 2.42% |
| 15 | ESSA PHARMA INC | 29668H708 | 4,288,167 | $26.0M | 2.01% |
| 16 | JASPER THERAPEUTICS INC | JSPRW | 1,343,665 | $25.3M | 1.96% |
| 17 | SURMODICS INC | 868873100 | 637,698 | $24.7M | 1.91% |
| 18 | NURIX THERAPEUTICS INC | NRIX | 1,065,834 | $23.9M | 1.85% |
| 19 | 10X GENOMICS INC | TXG | 951,000 | $21.5M | 1.66% |
| 20 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,090,984 | $21.0M | 1.63% |
| 21 | MERUS N V | N5749R100 | 398,321 | $19.9M | 1.54% |
| 22 | CASTLE BIOSCIENCES INC | CSTL | 662,332 | $18.9M | 1.46% |
| 23 | EDAP TMS S A | EDAP | 7,309,254 | $18.6M | 1.44% |
| 24 | BEIGENE LTD | BEIGF | 82,750 | $18.6M | 1.44% |
| 25 | CELCUITY INC | CELC | 1,245,387 | $18.6M | 1.44% |
| 26 | ELI LILLY & CO | LLY | 19,300 | $17.1M | 1.32% |
| 27 | NEUROPACE INC | NPCE | 2,433,168 | $17.0M | 1.31% |
| 28 | EVOLUS INC | EOLS | 1,037,680 | $16.8M | 1.30% |
| 29 | ALNYLAM PHARMACEUTICALS INC | ALNY | 59,400 | $16.3M | 1.26% |
| 30 | ANI PHARMACEUTICALS INC | ANIP | 269,000 | $16.0M | 1.24% |
| 31 | ELEVANCE HEALTH INC | ELV | 29,650 | $15.4M | 1.19% |
| 32 | RIGEL PHARMACEUTICALS INC | RIGL | 934,788 | $15.1M | 1.17% |
| 33 | PRAXIS PRECISION MEDICINES I | PRAX | 259,398 | $14.9M | 1.16% |
| 34 | KEROS THERAPEUTICS INC | KROS | 224,600 | $13.0M | 1.01% |
| 35 | CG ONCOLOGY INC | CGON | 340,585 | $12.9M | 1.00% |
| 36 | IMMUNIC INC | IMUX | 7,293,007 | $12.0M | 0.93% |
| 37 | BAUSCH HEALTH COS INC | 071734107 | 1,424,000 | $11.6M | 0.90% |
| 38 | PHARVARIS N V | PHVS | 598,169 | $11.1M | 0.86% |
| 39 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 318,269 | $10.6M | 0.82% |
| 40 | ORTHOFIX MED INC | OFIX | 606,933 | $9.5M | 0.73% |
| 41 | VERASTEM INC | VSTM | 2,827,963 | $8.5M | 0.65% |
| 42 | ENANTA PHARMACEUTICALS INC | ENTA | 785,546 | $8.1M | 0.63% |
| 43 | ORTHOPEDIATRICS CORP | KIDS | 288,945 | $7.8M | 0.61% |
| 44 | ARCELLX INC | ACLX | 93,031 | $7.8M | 0.60% |
| 45 | NUVALENT INC | NUVL | 74,357 | $7.6M | 0.59% |
| 46 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 302,500 | $7.6M | 0.59% |
| 47 | BIODESIX INC | BDSX | 4,038,065 | $7.2M | 0.56% |
| 48 | TAKEDA PHARMACEUTICAL CO LTD | TKPHF | 500,000 | $7.1M | 0.55% |
| 49 | RELAY THERAPEUTICS INC | RLAY | 910,000 | $6.4M | 0.50% |
| 50 | SUMMIT THERAPEUTICS INC | SMMT | 285,000 | $6.2M | 0.48% |
| 51 | ENLIVEN THERAPEUTICS INC | ELVN | 239,705 | $6.1M | 0.47% |
| 52 | BAUSCH PLUS LOMB CORP | 071705107 | 312,000 | $6.0M | 0.47% |
| 53 | THERATECHNOLOGIES INC | 88338H704 | 4,801,376 | $6.0M | 0.46% |
| 54 | ERASCA INC | ERAS | 2,162,162 | $5.9M | 0.46% |
| 55 | APPLIED THERAPEUTICS INC | 03828A101 | 680,784 | $5.8M | 0.45% |
| 56 | ADAPTIVE BIOTECHNOLOGIES COR | ADTI | 1,112,749 | $5.7M | 0.44% |
| 57 | ARVINAS INC | ARVN | 228,800 | $5.6M | 0.44% |
| 58 | ALECTOR INC | ALEC | 1,207,371 | $5.6M | 0.44% |
| 59 | ENGENE HOLDINGS INC | ENGNW | 800,000 | $5.3M | 0.41% |
| 60 | Y-MABS THERAPEUTICS INC | 984241109 | 399,982 | $5.3M | 0.41% |
| 61 | TREACE MED CONCEPTS INC | 89455T109 | 887,941 | $5.2M | 0.40% |
| 62 | SILENCE THERAPEUTICS PLC | SLNCF | 260,000 | $4.7M | 0.37% |
| 63 | BIOATLA INC | BCAB | 2,517,478 | $4.4M | 0.34% |
| 64 | DYNE THERAPEUTICS INC | DYN | 117,500 | $4.2M | 0.33% |
| 65 | INSULET CORP | PODD | 16,750 | $3.9M | 0.30% |
| 66 | INARI MED INC | 45332Y109 | 93,878 | $3.9M | 0.30% |
| 67 | NATERA INC | NTRA | 29,900 | $3.8M | 0.29% |
| 68 | INSPIREMD INC | NSPR | 1,378,128 | $3.7M | 0.29% |
| 69 | MEREO BIOPHARMA GROUP PLC | MREO | 846,953 | $3.5M | 0.27% |
| 70 | CALCIMEDICA INC | CALC | 783,904 | $3.5M | 0.27% |
| 71 | ABBVIE INC | ABBV | 15,750 | $3.1M | 0.24% |
| 72 | VAXCYTE INC | PCVX | 27,050 | $3.1M | 0.24% |
| 73 | TANGO THERAPEUTICS INC | TNGX | 343,152 | $2.6M | 0.20% |
| 74 | ESTABLISHMENT LABS HLDGS INC | ESTA | 59,400 | $2.6M | 0.20% |
| 75 | MDXHEALTH SA | MDXH | 1,105,000 | $2.3M | 0.18% |
| 76 | INSMED INC | INSM | 30,272 | $2.2M | 0.17% |
| 77 | VIRIDIAN THERAPEUTICS INC | VRDN | 95,000 | $2.2M | 0.17% |
| 78 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 287,246 | $2.0M | 0.16% |
| 79 | CERVOMED INC | CRVO | 126,614 | $1.8M | 0.14% |
| 80 | VERACYTE INC | VCYT | 54,303 | $1.8M | 0.14% |
| 81 | BICYCLE THERAPEUTICS PLC | BCYC | 78,315 | $1.8M | 0.14% |
| 82 | GSK PLC | GLAXF | 37,500 | $1.5M | 0.12% |
| 83 | ABIVAX SA | AAVXF | 125,000 | $1.4M | 0.11% |
| 84 | OLEMA PHARMACEUTICALS INC | OLMA | 103,500 | $1.2M | 0.10% |
| 85 | AADI BIOSCIENCE INC | WHWK | 333,227 | $686,448 | 0.05% |
| 86 | IMMUNOVANT INC | IMVT | 9,678 | $275,920 | 0.02% |
| 87 | IO BIOTECH INC | IOBT | 192,670 | $202,304 | 0.02% |